BI 695501 (Cyltezo®; adalimumab-adbm) in rheumatoid arthritis - VJBM

$ 25.50

4.7
(614)
In stock
Description

This video discusses the clinical equivalence of BI 695501 (Cyltezo®; adalimumab-adbm) and adalimumab for rheumatoid arthritis - the VOLTAIRE-RA and extension studies.

Sam Cavana on LinkedIn: Design of SERENA-6, a phase III switching trial of camizestrant in…

Evidence for Crohn's Disease

Evidence for Rheumatoid Arthritis

Product Profile of Boehringer Ingelheim's Adalimumab Biosimilar (Cyltezo)

cyltezo

Rheumatology Dosing & Administration

Home - Video Journal of Biomedicine

Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial

Cyltezo (adalimumab): Uses, Side Effects, Dosage & Reviews